Avicanna

Avicanna is a Canadian biopharmaceutical company specializing in the research, development, and commercialization of evidence-based cannabinoid products. With a strong focus on the global consumer, medical, and pharmaceutical markets, Avicanna offers a wide range of innovative and proprietary formulations. Their portfolio includes over 30 commercial products across four main market segments.

In the medical cannabis and wellness sector, Avicanna provides CBD cosmetics and skincare products marketed under the Pura H&W brand. These clinically tested derma-cosmetic products are available nationwide in Canada and in international markets. Avicanna also offers pharmaceutical preparations and pipeline drugs designed to address major clinical indications such as dermatology, chronic pain, and neurological disorders.

Additionally, their Aureus Santa Marta brand provides active pharmaceutical ingredients sourced from hemp and cannabis cultivars. With an industry-leading scientific platform, Avicanna is committed to setting the standard in the cannabinoid industry through advanced and evidence-based products. They have headquarters in Toronto and global offices in London and Miami.

Overall, Avicanna is dedicated to delivering high-quality, scientifically curated cannabinoid products for the global marketplace, catering to a range of consumer needs